Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proline rich 13 pseudogene 7 (PRR13P7) is annotated as a human pseudogene, meaning it is a DNA sequence related to a protein-coding gene but is nonfunctional due to mutations or genomic context. There is no protein product nor any known biological, therapeutic, or diagnostic relevance. Information on sequence, transcripts, and genomic location can be found via gene databases, but PRR13P7 has no known role in human health or disease. In summary: PRR13P7 is a pseudogene, not a functional protein, receptor, or enzyme, and it is not considered a current or plausible therapeutic target.
None.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline rich 13 pseudogene 7 (PRR13P7).